178 related articles for article (PubMed ID: 38254705)
1. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice.
Hao Q; Henning SM; Magyar CE; Said J; Zhong J; Rettig MB; Vadgama JV; Wang P
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254705
[TBL] [Abstract][Full Text] [Related]
2. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
Wang P; Vadgama JV; Said JW; Magyar CE; Doan N; Heber D; Henning SM
J Nutr Biochem; 2014 Jan; 25(1):73-80. PubMed ID: 24314868
[TBL] [Abstract][Full Text] [Related]
3. Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells.
Wang P; Phan T; Gordon D; Chung S; Henning SM; Vadgama JV
Mol Nutr Food Res; 2015 Feb; 59(2):250-61. PubMed ID: 25380086
[TBL] [Abstract][Full Text] [Related]
4. Arctigenin inhibits prostate tumor cell growth
Wang P; Solorzano W; Diaz T; Magyar CE; Henning SM; Vadgama JV
Clin Nutr Exp; 2017 Jun; 13():1-11. PubMed ID: 29062885
[TBL] [Abstract][Full Text] [Related]
5. Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.
Wang P; Henning SM; Magyar CE; Elshimali Y; Heber D; Vadgama JV
J Exp Clin Cancer Res; 2016 May; 35():73. PubMed ID: 27151407
[TBL] [Abstract][Full Text] [Related]
6. Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells.
Wang P; Wang B; Chung S; Wu Y; Henning SM; Vadgama JV
RSC Adv; 2014 Aug; 4(66):35242-35250. PubMed ID: 25243063
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.
Wang P; Henning SM; Heber D; Vadgama JV
J Nutr Biochem; 2015 Apr; 26(4):408-15. PubMed ID: 25655047
[TBL] [Abstract][Full Text] [Related]
8. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
[TBL] [Abstract][Full Text] [Related]
9. Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.
Koike H; Nozawa M; De Velasco MA; Kura Y; Ando N; Fukushima E; Yamamoto Y; Hatanaka Y; Yoshikawa K; Nishio K; Uemura H
Asian Pac J Cancer Prev; 2015; 16(5):1827-31. PubMed ID: 25773832
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.
Henning SM; Wang P; Lee RP; Trang A; Husari G; Yang J; Grojean EM; Ly A; Hsu M; Heber D; Grogan T; Li Z; Aronson WJ
Food Funct; 2020 May; 11(5):4114-4122. PubMed ID: 32347270
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin shows preferential cytotoxicity to acidity-tolerant prostate carcinoma PC-3 cells through ROS-mediated mitochondrial damage and the inhibition of PI3K/Akt/mTOR pathway.
Lee YJ; Oh JE; Lee SH
Biochem Biophys Res Commun; 2018 Nov; 505(4):1244-1250. PubMed ID: 30333093
[TBL] [Abstract][Full Text] [Related]
12. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
[TBL] [Abstract][Full Text] [Related]
13. Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.
Hao Q; Diaz T; Verduzco ADR; Magyar CE; Zhong J; Elshimali Y; Rettig MB; Henning SM; Vadgama JV; Wang P
Sci Rep; 2020 Jan; 10(1):1403. PubMed ID: 31996731
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention.
Jia S; Gao X; Lee SH; Maira SM; Wu X; Stack EC; Signoretti S; Loda M; Zhao JJ; Roberts TM
Cancer Discov; 2013 Jan; 3(1):44-51. PubMed ID: 23258246
[TBL] [Abstract][Full Text] [Related]
16. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Narayanan NK; Nargi D; Randolph C; Narayanan BA
Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets for green tea in prostate cancer prevention.
Adhami VM; Ahmad N; Mukhtar H
J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
[TBL] [Abstract][Full Text] [Related]
19. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer.
Yamamoto Y; De Velasco MA; Kura Y; Nozawa M; Hatanaka Y; Oki T; Ozeki T; Shimizu N; Minami T; Yoshimura K; Yoshikawa K; Nishio K; Uemura H
J Transl Med; 2015 May; 13():150. PubMed ID: 25953027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
